At least seven breast cancer studies conducted since 2001 have supported the evidence for an increased response to celexa in women with.
Kuhlolwa njalo njalo kwalesifo kubomake labatitfwele emitfolampilo kunetinkomba tekukhula kwelizinga lalesifo kulelakaNgwane. luhlolo kubomake labatitfwele lolwentiwe ngemnyaka wanga 2004.